News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
CLACKSON TIMOTHY P
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/02/2023 |
4
| CLACKSON TIMOTHY P (President and CEO) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Granted 45,625 restricted stock units
@ $0 |
|
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/14/2022 |
4
| CLACKSON TIMOTHY P (Director) has filed a Form 4 on Forma Therapeutics Holdings, Inc.|
Txns:
| Unknown transaction of 23,590 shares
@ $0
Unknown transaction of 7,250 shares
@ $0
Disposed/sold 14,026 options to buy
@ $5.05, valued at
$70.8k
Disposed/sold 9,351 options to buy
@ $5.05, valued at
$47.2k
Disposed/sold 28,053 options to buy
@ $5.43, valued at
$152.3k
Disposed/sold 17,533 options to buy
@ $20, valued at
$350.7k
Disposed/sold 8,375 options to buy
@ $25.35, valued at
$212.3k
Disposed/sold 6,750 options to buy
@ $6.12, valued at
$41.3k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| CLACKSON TIMOTHY P (Director) has filed a Form 4 on Forma Therapeutics Holdings, Inc.|
Txns:
| Granted 4,500 shares
@ $0
Granted 6,750 options to buy
@ $6.12, valued at
$41.3k
|
|
| 02/23/2022 |
4
| CLACKSON TIMOTHY P (President and CEO) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Granted 450,000 options to buy
@ $11.21, valued at
$5M
|
|
| 12/22/2021 |
4
| CLACKSON TIMOTHY P (President and CEO) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Bought 2,600 shares
@ $9.7621, valued at
$25.4k
|
|
| 06/21/2021 |
4
| CLACKSON TIMOTHY P (Director) has filed a Form 4 on Forma Therapeutics Holdings, Inc.|
Txns:
| Granted 2,750 shares
@ $0
Granted 8,375 options to buy
@ $25.35, valued at
$212.3k
|
|
| 10/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2020 |
4
| CLACKSON TIMOTHY P (Director) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Granted 8,588 shares
@ $0 |
|
| 06/25/2020 |
4
| CLACKSON TIMOTHY P (Director) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Granted 7,500 options to buy
@ $1.6, valued at
$12k
|
|
| 06/24/2020 |
4
| CLACKSON TIMOTHY P (Director) has filed a Form 4 on Forma Therapeutics Holdings, Inc.,|
Txns:
| Bought 23,590 shares
@ $0
Sold 35,067 shares
@ $0 |
|
| 06/22/2020 |
4
| CLACKSON TIMOTHY P (Director) has filed a Form 4 on Forma Therapeutics Holdings, Inc.,|
Txns:
| Granted 17,533 options to buy
@ $20, valued at
$350.7k
|
|
| 04/01/2020 |
4
| CLACKSON TIMOTHY P (Director) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Granted 13,575 shares
@ $0 |
|
| 01/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2019 |
4
| CLACKSON TIMOTHY P (Director) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Granted 3,670 shares
@ $0 |
|
| 07/11/2019 |
4
| CLACKSON TIMOTHY P (Director) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Granted 7,500 options to buy
@ $4.62, valued at
$34.7k
|
|
| 07/01/2019 |
4
| CLACKSON TIMOTHY P (Director) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Granted 3,421 shares
@ $0 |
|
| 04/02/2019 |
4
| CLACKSON TIMOTHY P (Director) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Granted 1,204 shares
@ $0 |
|
| 01/03/2019 |
4
| CLACKSON TIMOTHY P (Director) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Granted 1,083 shares
@ $0 |
|
| 10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2018 |
4
| CLACKSON TIMOTHY P (Director) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Granted 744 shares
@ $0 |
|
| 03/05/2018 |
4
| CLACKSON TIMOTHY P (Director) has filed a Form 4 on Spring Bank Pharmaceuticals, Inc.|
Txns:
| Granted 11,000 options to buy
@ $13.1, valued at
$144.1k
|
|
| 02/16/2017 |
4
| CLACKSON TIMOTHY P (President, R&D, CSO) has filed a Form 4 on ARIAD PHARMACEUTICALS INC|
Txns:
| Disposed/sold 219,867 shares
@ $0
Disposed/sold 577 shares
@ $0
Disposed/sold 82,000 options to buy
@ $15.05, valued at
$1.2M
Disposed/sold 65,000 options to buy
@ $20.89, valued at
$1.4M
Disposed/sold 87,125 options to buy
@ $6.51, valued at
$567.2k
Disposed/sold 72,980 restricted stock units
@ $0
Disposed/sold 14,550 restricted stock units
@ $0 |
|
| 02/07/2017 |
4
| CLACKSON TIMOTHY P (President, R&D, CSO) has filed a Form 4 on ARIAD PHARMACEUTICALS INC|
Txns:
| Granted 14,550 restricted stock units
@ $0 |
|
| 02/02/2017 |
4
| CLACKSON TIMOTHY P (President, R&D, CSO) has filed a Form 4 on ARIAD PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 9,610 shares
@ $23.8175, valued at
$228.9k
Exercised 29,333 restricted stock units
@ $0 |
|
| 10/25/2016 |
4
| CLACKSON TIMOTHY P (President, R&D, CSO) has filed a Form 4 on ARIAD PHARMACEUTICALS INC|
Txns:
| Sold 19,638 shares
@ $9.56, valued at
$187.7k
|
|
| 09/28/2016 |
4
| CLACKSON TIMOTHY P (President, R&D, CSO) has filed a Form 4 on ARIAD PHARMACEUTICALS INC|
Txns:
| Sold 8,750 shares
@ $13.9784, valued at
$122.3k
Exercised 17,500 rights
@ $0 |
|
| 09/23/2016 |
4
| CLACKSON TIMOTHY P (President, R&D, CSO) has filed a Form 4 on ARIAD PHARMACEUTICALS INC|
Txns:
| Sold 20,000 shares
@ $13.4268, valued at
$268.5k
|
|
| 09/16/2016 |
4
| CLACKSON TIMOTHY P (President, R&D, CSO) has filed a Form 4 on ARIAD PHARMACEUTICALS INC|
Txns:
| Sold 59,369 shares
@ $11.73, valued at
$696.4k
Exercised 59,369 options to buy
@ $7.82, valued at
$464.3k
|
|
| 07/25/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/23/2016 |
4
| CLACKSON TIMOTHY P (President, R&D, CSO) has filed a Form 4 on ARIAD PHARMACEUTICALS INC|
Txns:
| Sold 23,999 shares
@ $7.2769, valued at
$174.6k
|
|
| 05/25/2016 |
4
| CLACKSON TIMOTHY P (President, R&D, CSO) has filed a Form 4 on ARIAD PHARMACEUTICALS INC|
Txns:
| Sold 17,762 shares
@ $8.0751, valued at
$143.4k
|
|
|
|
|